FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teligent Pharma Erythromycin Topical Gel Recall

Erythromycin Topical Gel USP, 2%

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class II
Reported by FDA
Feb 23, 2022
Recall ID
D-0716-2022
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Erythromycin Topical Gel starting Feb 7, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0716-2022 on Feb 23, 2022. Reason: Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.

Product description

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

Lot numbers, UPCs & expiration codes

Lot: 15724, Exp. 06/2022

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0716-2022
Classification
Class II
Status
Terminated
Recall initiated
Feb 7, 2022
FDA report date
Feb 23, 2022
Quantity
11040 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0716-2022, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Terminated
Country
United States
Event ID
89560
Address
105 Lincoln Avenue
Code information
Lot: 15724, Exp. 06/2022
Postal code
08310
Report date
Feb 23, 2022
Product type
Drugs
Recall number
D-0716-2022
Classification
Class II
Recalling firm
Teligent Pharma, Inc.
Product quantity
11040 tubes
Termination date
May 9, 2024
Reason for recall
Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Feb 7, 2022
Initial firm notification
Letter
Center classification date
Mar 24, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0716-2022, published Feb 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls